May 03,2022

Telehealth cancer care consultations during the COVID-19 pandemic: a qualitative study of the experiences of Australians affected by cancer

In response to the onset of the COVID-19 pandemic, telehealth was rapidly rolled out in health services across Australia including those delivering cancer care. This study aimed to understand people with cancer and carers’ experiences with telehealth for cancer care during the COVID-19 pandemic and associated restrictions.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
May 27,2022

Researchers Use AI to Predict Cancer Risk of Lung Nodules

An artificial intelligence (AI) tool helps doctors predict the cancer risk in lung nodules seen on CT, according to a new study published in the journal Radiology. Pulmonary nodules appear as small spots on the lungs on chest imaging. They have become a much more common finding as CT has gained favor over X-rays for chest imaging.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
May 19,2022

Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study

During and after systemic therapy, patients with high risk and advanced melanoma experience challenges regarding cancer-related symptoms, treatment-related adverse events, and an impact of these symptoms on their physical and psychosocial well-being. Few studies have investigated the specific needs of these patients and the potential role of eHealth applications in meeting those needs.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
May 24,2022

An examination of depression, anxiety, and fear of recurrence among cancer survivors who participated in a virtual cognitive behavioral therapy (CBT)-based telephone coaching program

Depression, anxiety, and fear of recurrence (FOR) are prevalent among cancer survivors, and it is recommended that they have access to supportive services and resources to address psychosocial needs during follow-up care. This study examined the impact of a virtual cognitive behavioral therapy (CBT)-based telephone coaching program (BounceBack®) on depression, anxiety, and FOR.

CLINICAL STUDY

#coaching

View Analyst & Ambassador Comments
Go to original news
Jul 29,2022

AI System that Mimics Human Gaze could be Used to Detect Cancer

A cutting-edge artificial intelligence (AI) system that can accurately predict the areas of an image where a person is most likely to look has been created by scientists at Cardiff University. Based on the mechanics of the human brain and its ability to distinguish between different parts of an image, the researchers say the novel system more accurately represents human vision than anything that has gone before.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 12,2022

Effectiveness of psychoeducation intervention among women with gynecological cancer: a systematic review and meta-analysis of randomized controlled trials

Psychoeducation interventions have been suggested to improve sexual functioning and quality of life. The aim of this study was to examine the effects of the psychoeducation intervention on quality of life, sexual function, and psychological outcomes; and to identify the critical components of psychoeducation intervention for women with gynecological cancer. The results show that incorporating lecture-based, practical skills, discussion, and counseling through an online format and involving significant others are beneficial for improving the quality of life and sexual functioning among women with gynecological cancer.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jul 28,2022

A common infrastructure for real-world patient-reported symptoms: one size fits many

Researchers now advocate a broadly accessible, common infrastructure for patient-reported toxicities from all patients—in the so-called real-world—to facilitate enhanced collection of clinically meaningful and actionable data.

CLINICAL STUDY

#rwd

View Analyst & Ambassador Comments
Go to original news
Jul 14,2022

Florida Cancer Specialists & Research Institute Participating in Global Clinical Trial Analyzing Patient Responsiveness to Immunotherapy Treatment

Florida Cancer Specialists & Research Institute medical oncologist Ernest Bustinza-Linares, MD is serving as a Principal Investigator in a global clinical trial collaboration that will analyze the responsiveness of certain cancer patients to immunotherapy treatment. FCS is one of 35 clinical trial sites globally participating in the study hosted by OncoHost, a global leader in next-generation precision oncology. OncoHost’s first-of-its-kind precision diagnostic platform, PROphet®, will be used to analyze patient response and identify resistance to immunotherapy.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 22,2022

JITC Publishes OncoHost Study Identifying Predictive Proteomic Signature to Analyze Treatment Resistance in NSCLC Patients

OncoHost, a global company in next-generation precision oncology for improved personalized cancer therapy, announced a peer-reviewed article published in Journal for Immunotherapy of Cancer (JITC), a BMJ oncology journal. The study highlights the role of blood plasma proteomic profiling for assessing resistance in non-small cell lung cancer patients being treated with immune checkpoint inhibitors.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Aug 08,2022

New AI Technology Integrates Multiple Data Types to Predict Cancer Outcomes

While it's long been understood that predicting outcomes in patients with cancer requires considering many factors, such as patient history, genes and disease pathology, clinicians struggle with integrating this information to make decisions about patient care. A new study from researchers from the Mahmood Lab at Brigham and Women's Hospital reveals a proof-of-concept model that uses artificial intelligence (AI) to combine multiple types of data from different sources to predict patient outcomes for 14 different types of cancer. Results are published in Cancer Cell.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Subscribe to CLINICAL STUDY